GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aptose Biosciences Inc (FRA:LTI0) » Definitions » Cyclically Adjusted FCF per Share

Aptose Biosciences (FRA:LTI0) Cyclically Adjusted FCF per Share : €-253.96 (As of Mar. 2025)


View and export this data going back to 2014. Start your Free Trial

What is Aptose Biosciences Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Aptose Biosciences's adjusted free cash flow per share for the three months ended in Mar. 2025 was €-1.216. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is €-253.96 for the trailing ten years ended in Mar. 2025.

During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 10.10% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 16.60% per year. During the past 10 years, the average Cyclically Adjusted FCF Growth Rate was 26.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Aptose Biosciences was 33.50% per year. The lowest was 6.80% per year. And the median was 20.60% per year.

As of today (2025-06-28), Aptose Biosciences's current stock price is €0.69. Aptose Biosciences's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2025 was €-253.96. Aptose Biosciences's Cyclically Adjusted Price-to-FCF of today is .


Aptose Biosciences Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Aptose Biosciences's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aptose Biosciences Cyclically Adjusted FCF per Share Chart

Aptose Biosciences Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -449.96 -349.71 -322.80 -291.75 -252.17

Aptose Biosciences Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -261.60 -275.34 -256.09 -252.17 -253.96

Competitive Comparison of Aptose Biosciences's Cyclically Adjusted FCF per Share

For the Biotechnology subindustry, Aptose Biosciences's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aptose Biosciences's Cyclically Adjusted Price-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Aptose Biosciences's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Aptose Biosciences's Cyclically Adjusted Price-to-FCF falls into.


;
;

Aptose Biosciences Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Aptose Biosciences's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2025 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=-1.216/129.1809*129.1809
=-1.216

Current CPI (Mar. 2025) = 129.1809.

Aptose Biosciences Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201506 -121.462 100.500 -156.124
201509 -66.885 100.421 -86.040
201512 -109.296 99.947 -141.264
201603 -115.963 101.054 -148.240
201606 -118.444 102.002 -150.005
201609 -76.552 101.765 -97.176
201612 -89.355 101.449 -113.781
201703 -63.615 102.634 -80.070
201706 -50.000 103.029 -62.692
201709 -33.094 103.345 -41.368
201712 -40.661 103.345 -50.826
201803 -50.877 105.004 -62.591
201806 -105.960 105.557 -129.674
201809 -50.039 105.636 -61.192
201812 -60.145 105.399 -73.716
201903 -48.697 106.979 -58.803
201906 -45.495 107.690 -54.574
201909 -38.577 107.611 -46.309
201912 -43.208 107.769 -51.793
202003 -43.515 107.927 -52.084
202006 -37.840 108.401 -45.094
202009 -36.759 108.164 -43.901
202012 -43.081 108.559 -51.264
202103 -44.091 110.298 -51.640
202106 -36.995 111.720 -42.777
202109 -35.374 112.905 -40.473
202112 -71.412 113.774 -81.082
202203 -42.722 117.646 -46.911
202206 -32.629 120.806 -34.891
202209 -34.385 120.648 -36.817
202212 -39.839 120.964 -42.545
202303 -51.243 122.702 -53.949
202306 -60.048 124.203 -62.454
202309 -45.704 125.230 -47.146
202312 -32.408 125.072 -33.473
202403 -24.708 126.258 -25.280
202406 -9.620 127.522 -9.745
202409 -15.103 127.285 -15.328
202412 -3.837 127.364 -3.892
202503 -1.216 129.181 -1.216

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Aptose Biosciences  (FRA:LTI0) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Aptose Biosciences Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Aptose Biosciences's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Aptose Biosciences Business Description

Industry
Traded in Other Exchanges
Address
66 Wellington Street West, Suite 5300, TD Bank Tower Box 48, Toronto, ON, CAN, M5K 1E6
Aptose Biosciences Inc is a clinical-stage biotechnology company committed to discovering and developing personalized therapies addressing unmet medical needs in oncology. The company's small molecule cancer therapeutics pipeline includes products designed to provide single agent efficacy and to enhance the efficacy of other anti-cancer therapies and regimens without overlapping toxicities.

Aptose Biosciences Headlines

No Headlines